These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6207964)

  • 21. Induction chemotherapy with vinblastine, bleomycin, and cis-diamminedichloroplatinum in squamous cell carcinoma of the head and neck.
    Davis RK; Perry DJ; Zajtchuk JT
    Otolaryngol Head Neck Surg; 1983 Dec; 91(6):627-31. PubMed ID: 6198614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival after "palliative" cytotoxic chemotherapy for head-and-neck cancer.
    Stell PM; Morton RP; Campbell IT; Wilson JA
    Lancet; 1983 Nov; 2(8360):1205. PubMed ID: 6196584
    [No Abstract]   [Full Text] [Related]  

  • 23. Cisplatin-vincristine-bleomycin therapy in squamous cell carcinoma of the head and neck.
    Amrein PC; Fingert H; Weitzman SA
    J Clin Oncol; 1983 Jul; 1(7):421-7. PubMed ID: 6199477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate.
    Williams SD; Velez-Garcia E; Essessee I; Ratkin G; Birch R; Einhorn LH
    Cancer; 1986 Jan; 57(1):18-23. PubMed ID: 2416423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of treatment failure patterns. A Southwest Oncology Group Study.
    Schuller DE; Stein DW; Metch B
    Arch Otolaryngol Head Neck Surg; 1989 Jul; 115(7):834-6. PubMed ID: 2472157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant chemotherapy in stage III and IV squamous cell carcinoma of the head and neck.
    Klima A; Klippstein T; Bergmann L; Szepesi S; Ilberg CV
    J Laryngol Otol; 1988 Apr; 102(4):337-40. PubMed ID: 2455011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Induction chemotherapy with cisplatin and peplomycin in squamous cell carcinoma of the head and neck].
    Takagi T; Sakai C; Oguro M; Omura K; Shimada H; Takemiya S; Kuwahara T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):543-6. PubMed ID: 2434031
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC; Fabian RL
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer.
    Vogl SE; Schoenfeld DA; Kaplan BH; Lerner HJ; Engstrom PF; Horton J
    Cancer; 1985 Aug; 56(3):432-42. PubMed ID: 2408735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer.
    Cognetti F; Pinnarò P; Carlini P; Ruggeri EM; Ambesi Impiombato F; Del Vecchio MR; Giannarelli D; Perrino A
    Cancer; 1988 Jul; 62(2):251-61. PubMed ID: 2454721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial of combined multidrug chemotherapy and radiotherapy in advanced squamous cell carcinoma of the head and neck. An interim report from the SECOG participants. South-East Co-operative Oncology Group.
    Eur J Surg Oncol; 1986 Sep; 12(3):289-95. PubMed ID: 2428668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cis-dichlorodiammineplatinum(II), methotrexate, bleomycin, and vincristine in head and neck cancer: a pilot study.
    King GW; Halpin JJ; Smith RE; Batley F; Schuller DE
    Cancer Treat Rep; 1979; 63(11-12):1735-8. PubMed ID: 93508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck.
    Ensley JF; Jacobs JR; Weaver A; Kinzie J; Crissman J; Kish JA; Cummings G; Al-Sarraf M
    Cancer; 1984 Sep; 54(5):811-4. PubMed ID: 6204738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDDP and 5-FU after prior VBM or VBM after prior CDDP and 5-FU in the management of recurrent squamous cell carcinoma of the head and neck?
    Grimaldi A; Merlano M; Gardin G; Rosso R
    Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1539-40. PubMed ID: 2439343
    [No Abstract]   [Full Text] [Related]  

  • 35. Combined modality therapy utilizing a cisplatin combination for effective chemotherapy in patients with previously untreated head and neck cancer.
    Jacobs JR; Kish J; Ensley JF; Ahmad K; Weaver A; Crissman J; Al-Sarraf M
    Am J Surg; 1986 Oct; 152(4):451-5. PubMed ID: 2429570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integration of safe initial combination chemotherapy (without cisplatin) with a high response rate and local therapy for untreated stage III and IV epidermoid cancer of the head and neck: 5-year survival data.
    Price LA; MacRae K; Hill BT
    Cancer Treat Rep; 1983 Jun; 67(6):535-9. PubMed ID: 6190557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of complete responders after initial treatment with chemotherapy in head and neck cancer.
    Kies MS; Gordon LI; Hauck WW; Krespi Y; Ossoff RH; Pecaro BC; Yuska C; Lamut CH; Brand WN; Chang SK
    Otolaryngol Head Neck Surg; 1985 Apr; 93(2):199-205. PubMed ID: 2581211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study of 2 chemotherapy induction protocols. Cisplatinum-methotrexate-bleomycin and oncovin-methotrexate-bleomycin].
    Laccourreye H; Beutter P; Brasnu D; Lacau-Saint-Guily J; Bassot V; Garabedian N; Jacquillat C
    Ann Otolaryngol Chir Cervicofac; 1983; 100(4):269-74. PubMed ID: 6192747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of two neoadjuvant protocols (VBM and DDP-BLM) combined with radiation therapy in advanced head and neck cancer.
    Amichetti M; Valentini A
    J Chemother; 1989 Feb; 1(1):68-71. PubMed ID: 2470865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [2d interim evaluation of a chemotherapy study on patients with squamous cell carcinomas of the head-neck area. A comparison of 2 therapy regimens: cis-diamminedichloroplatinum (II) and bleomycin versus methotrexate and vindesine].
    Schröder M; von Heyden HW; Scherpe A; Borghardt J; Beyer JH; Nagel GA; Gerhartz H; Kastenbauer E; Westerhausen M; Schroeder M; Caliebe W; Rudert H; Lissers R; Hofmann J; Schneider B
    Onkologie; 1983 Jun; 6(3):114-7. PubMed ID: 6193472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.